Financial Information

Tax Information Letter    Form 10 Information Statement

Myriad Genetics, Inc.'s latest financial information is provided below. We are a July 1 to June 30 fiscal year company.

Latest Earnings Release and 10-Q Date Filed Format Size  
Third Quarter Financial Results HTML file N/A  
Form 10-Q May 8, 2013 HTML file  PDF file   View XBRL 285.7 KB Add to Briefcase
Form 10-Q Feb 6, 2013 HTML file  PDF file   View XBRL 288.0 KB Add to Briefcase
 
Latest Annual Report and 10-K Date Filed Format Size  
Annual Report 2012   PDF 970.9 KB Add to Briefcase
Form 10-K Aug 15, 2012 HTML file  PDF file   View XBRL 930.0 KB Add to Briefcase
 
Latest Proxy Statement Date Filed Format Size  
Proxy Statement (DEFA14A) Oct 12, 2012 HTML file  PDF file 39.8 KB Add to Briefcase
Proxy Statement Oct 12, 2012 HTML file  PDF file 894.8 KB Add to Briefcase

Add to Briefcase = add PDF file to Briefcase

Stock Quote (NASDAQ:MYGN)

Price:
25.88
Change:
- 0.56
Open:
26.32
Previous Close:
26.44
Day High:
27.11
Day Low:
25.79
52 Week High:
38.27
52 Week Low:
22.02
Volume:
2,812,300
4:02 PM ET on Jun 19, 2013
Delayed at least 20 minutes.
Provided by eSignal.

Investor Contact

Scott Gleason
(801) 584-1143
sgleason@myriad.com

Media Contact

Ron Rogers
Corporate Communications and Media Relations
(801) 584-3065
rrogers@myriad.com